AI assistant
Medtronic plc — Director's Dealing 2015
Dec 8, 2015
29841_dirs_2015-12-08_bbbc2b34-9c5f-4cb9-ac22-b123318ec3da.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 4 — Statement of Changes in Beneficial Ownership
Issuer: Medtronic plc (MDT)
CIK: 0001613103
Period of Report: 2015-12-04
Reporting Person: Kuntz Richard (N/A)
Non-Derivative Transactions
| Date | Security | Code | Shares | Price | A/D | Holdings After | Ownership |
|---|---|---|---|---|---|---|---|
| 2015-12-04 | Ordinary Shares | M | 15401 | $48.7 | Acquired | 121801 | Direct |
| 2015-12-04 | Ordinary Shares | S | 13715 | $78.0637 | Disposed | 108086 | Direct |
Derivative Transactions
| Date | Security | Exercise Price | Code | Shares | A/D | Expiration | Underlying | Ownership |
|---|---|---|---|---|---|---|---|---|
| 2015-12-04 | Employee Stock Option (right to buy) | $48.7 | M | 15401 | Disposed | 2016-10-30 | Ordinary Shares (15401) | Direct |
Footnotes
F1: This balance increased by 269 shares due to exempt transactions such as dividend reinvestment.
F2: These options become exercisable at the rate of 25% of the shares granted per year beginning on the first anniversary of grant.
F3: The price in column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $78.0500 to $78.0900, inclusive. The reporting person undertakes to provide to Medtronic plc, any security holder of Medtronic plc, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in the footnote to this Form 4.